Cordlife
News
CyGenics Ltd (ASX: CYN) announced today that it has taken a 51% controlling equity interest in BioCell Pty Ltd, an Australian cord blood stem cell banking business.
###
6,072 COMPANY PROFILE VIEWS
- This Page Viewed: (Last 7 Days: 25) (Last 30 Days: 96) (Since Published: 6072)
